Literature DB >> 8690908

Identification of a contact region for peptide on the TAP1 chain of the transporter associated with antigen processing.

M Nijenhuis1, S Schmitt, E A Armandola, R Obst, J Brunner, G J Hämmerling.   

Abstract

The transporter associated with Ag processing (TAP) translocates cytosolic peptides into the endoplasmic reticulum for presentation by MHC class 1 molecules. Recently, the actual peptide translocation step has been suggested to be preceded by binding of the peptide to TAP. In this study, we investigated the peptide binding site of TAP and its relevance for peptide selection by cross-linking of translocatable peptides. Our data demonstrate, first, that for a TAP heterodimer containing the rat TAPu allelic product, which selects peptides on basis of their C terminus, the translocation efficiency correlates with the peptide binding efficiency. Second, peptides having the cross-linker at different positions all label both the TAP1 and the TAP2 subunit after binding to the heterodimer, indicating that both TAP subunits contribute directly to the peptide binding site and contact most or all amino acids of a bound peptide. Third, by enzymatic digestion and the use specific antisera, we identified a domain of human TAP1 that contributes to the peptide binding site. This domain contains the two hydrophobic and thus putative transmembrane regions closest to the ATP binding sites. We conclude that the peptide binding site controls the selectivity of TAP and is composed of domains of both TAP1 and TAP2, which each contact the bound peptide over all or most of its length. Moreover, the major contact site(s) for peptide on TAP1 are located within or close to the two putative transmembrane regions adjacent to the ATP binding site.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8690908

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  The human cytomegalovirus gene product US6 inhibits ATP binding by TAP.

Authors:  E W Hewitt; S S Gupta; P J Lehner
Journal:  EMBO J       Date:  2001-02-01       Impact factor: 11.598

2.  Single residue within the antigen translocation complex TAP controls the epitope repertoire by stabilizing a receptive conformation.

Authors:  Christoph Baldauf; Susanne Schrodt; Meike Herget; Joachim Koch; Robert Tampé
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-03       Impact factor: 11.205

3.  Chicken TAP genes differ from their human orthologues in locus organisation, size, sequence features and polymorphism.

Authors:  Brian A Walker; Andrew van Hateren; Sarah Milne; Stephan Beck; Jim Kaufman
Journal:  Immunogenetics       Date:  2005-04-02       Impact factor: 2.846

4.  ER-60, a chaperone with thiol-dependent reductase activity involved in MHC class I assembly.

Authors:  J A Lindquist; O N Jensen; M Mann; G J Hämmerling
Journal:  EMBO J       Date:  1998-04-15       Impact factor: 11.598

Review 5.  Peptide selection for presentation by HLA class I: a role for the human transporter associated with antigen processing?

Authors:  P M van Endert
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

6.  Interactions formed by individually expressed TAP1 and TAP2 polypeptide subunits.

Authors:  Antony N Antoniou; Stuart Ford; Elizabeth S Pilley; Neil Blake; Simon J Powis
Journal:  Immunology       Date:  2002-06       Impact factor: 7.397

7.  Use of Functional Polymorphisms To Elucidate the Peptide Binding Site of TAP Complexes.

Authors:  Jie Geng; Irina D Pogozheva; Henry I Mosberg; Malini Raghavan
Journal:  J Immunol       Date:  2015-08-31       Impact factor: 5.422

8.  PRED(TAP): a system for prediction of peptide binding to the human transporter associated with antigen processing.

Authors:  Guang Lan Zhang; Nikolai Petrovsky; Chee Keong Kwoh; J Thomas August; Vladimir Brusic
Journal:  Immunome Res       Date:  2006-05-23

9.  The active site of ICP47, a herpes simplex virus-encoded inhibitor of the major histocompatibility complex (MHC)-encoded peptide transporter associated with antigen processing (TAP), maps to the NH2-terminal 35 residues.

Authors:  B Galocha; A Hill; B C Barnett; A Dolan; A Raimondi; R F Cook; J Brunner; D J McGeoch; H L Ploegh
Journal:  J Exp Med       Date:  1997-05-05       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.